Common Contracts

RESEARCH COLLABORATION AND OPTION AGREEMENT between JANSSEN PHARMACEUTICALS, INC. and MORPHIC THERAPEUTIC, INC. DATED: FEBRUARY 15, 2019

Research Collaboration and Option Agreement • June 14th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Research Collaboration and Option Agreement
• Filed
  June 14th, 2019
• Company
  Morphic Holding, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Research Collaboration and Option Agreement (this “Agreement”), dated as of February , 2019 (the “Effective Date”), is made by and between Morphic Therapeutic, Inc. having an office at 35 Gatehouse Drive A2, Waltham, MA 02451 92121 (“Morphic”), and Janssen Pharmaceuticals, Inc. having an office at 1125 Trenton-Harbourton Road, Titusville, NJ 08560 (“Janssen”). Each of Morphic and Janssen may be referred to herein as a “Party” or together as the “Parties.”

RESEARCH COLLABORATION AND OPTION AGREEMENT between JANSSEN PHARMACEUTICALS, INC. and MORPHIC THERAPEUTIC, INC. DATED: FEBRUARY 15, 2019

Research Collaboration and Option Agreement • May 30th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Research Collaboration and Option Agreement
• Filed
  May 30th, 2019
• Company
  Morphic Holding, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Research Collaboration and Option Agreement (this “Agreement”), dated as of February , 2019 (the “Effective Date”), is made by and between Morphic Therapeutic, Inc. having an office at 35 Gatehouse Drive A2, Waltham, MA 02451 92121 (“Morphic”), and Janssen Pharmaceuticals, Inc. having an office at 1125 Trenton-Harbourton Road, Titusville, NJ 08560 (“Janssen”). Each of Morphic and Janssen may be referred to herein as a “Party” or together as the “Parties.”

RESEARCH COLLABORATION AND OPTION AGREEMENT between JANSSEN PHARMACEUTICALS, INC. and MORPHIC THERAPEUTIC, INC. DATED: FEBRUARY 15, 2019

Research Collaboration and Option Agreement • May 22nd, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Research Collaboration and Option Agreement
• Filed
  May 22nd, 2019
• Company
  Morphic Holding, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Research Collaboration and Option Agreement (this “Agreement”), dated as of February , 2019 (the “Effective Date”), is made by and between Morphic Therapeutic, Inc. having an office at 35 Gatehouse Drive A2, Waltham, MA 02451 92121 (“Morphic”), and Janssen Pharmaceuticals, Inc. having an office at 1125 Trenton-Harbourton Road, Titusville, NJ 08560 (“Janssen”). Each of Morphic and Janssen may be referred to herein as a “Party” or together as the “Parties.”